|
|
|
| home > pmps > autumn 2003 > high purity gas generation for use in drug delivery preparation and pharmaceutical manufacturing |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
The types and uses of process gases in drug delivery preparation and pharmaceutical manufacturing are many and varied. The virtually inert attributes of nitrogen make it suitable for blanketing and purging, while hydrogen, zero-air, TOC-free air, along with nitrogen all find uses within manufacturing process quality laboratories. Today it is possible to generate all of these gases on-site using standalone gas generators.
Applications of High Purity Gases in Drug Delivery and Manufacturing
The diversity of applications for high purity gases within pharmaceutical manufacturing is extremely wide-ranging. It is worthwhile mentioning some of the most common. Blanketing with nitrogen is an important process used to protect volatile substances, which react with oxygen or water vapour. By surrounding the substance with a protective layer of dry, inert gas, the stability of the substance can be maintained without any degradation. Controlled flow may be used to preserve the density of the nitrogen blanket. Purging involves the flushing of a vessel with nitrogen to dispel oxygen and moisture, usually at process start-up or shutdown.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
Clinerion is part of Citeline, a Norstella company!
January 30, 2023 – We are pleased to
officially announce that Clinerion has become part of Citeline, a
Norstella company. Norstella is now poised to be one of the world’s
largest pharma intelligence solutions providers on the market.
More info >> |
|
 |
White Papers |
 |
|
The Impact of Components on Drug Quality and Risk Mitigation
West Pharmaceutical Services, Inc.
Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >> |
|
|
